| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
|
Till, Brian G.
|
|
|
112 |
6 |
p. 2261-2271
|
artikel
|
| 2 |
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
|
Buller, Harry R.
|
|
|
112 |
6 |
p. 2242-2247
|
artikel
|
| 3 |
A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo
|
Okada, Yoshiaki
|
|
|
112 |
6 |
p. 2336-2339
|
artikel
|
| 4 |
A mechanism for the HLA-A*01–associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis
|
Brennan, Rebekah M.
|
|
|
112 |
6 |
p. 2589-2590
|
artikel
|
| 5 |
Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles
|
Dalli, Jesmond
|
|
|
112 |
6 |
p. 2512-2519
|
artikel
|
| 6 |
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
|
Peipp, Matthias
|
|
|
112 |
6 |
p. 2390-2399
|
artikel
|
| 7 |
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)
|
Mead, Graham M.
|
|
|
112 |
6 |
p. 2248-2260
|
artikel
|
| 8 |
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration
|
van de Ven, Rieneke
|
|
|
112 |
6 |
p. 2353-2359
|
artikel
|
| 9 |
Chromosomal translocations: revisited yet again
|
Rowley, Janet D.
|
|
|
112 |
6 |
p. 2183-2189
|
artikel
|
| 10 |
Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan
|
Narimatsu, Hiroto
|
|
|
112 |
6 |
p. 2579-2582
|
artikel
|
| 11 |
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor
|
Lin, Julie H.
|
|
|
112 |
6 |
p. 2484-2488
|
artikel
|
| 12 |
Disease anticipation in familial myeloproliferative neoplasms
|
Rumi, Elisa
|
|
|
112 |
6 |
p. 2587-2588
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
112 |
6 |
p. i
|
artikel
|
| 14 |
Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells
|
Tu, Wenwei
|
|
|
112 |
6 |
p. 2554-2562
|
artikel
|
| 15 |
Expression, activation, and function of integrin αMβ2 (Mac-1) on neutrophil-derived microparticles
|
Pluskota, Elzbieta
|
|
|
112 |
6 |
p. 2327-2335
|
artikel
|
| 16 |
FIP1L1/PDGFRα's Kit to stimulate mast cells
|
Cools, Jan
|
|
|
112 |
6 |
p. 2179
|
artikel
|
| 17 |
FIP1L1/PDGFRα synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome
|
Yamada, Yoshiyuki
|
|
|
112 |
6 |
p. 2500-2507
|
artikel
|
| 18 |
FLT3 ligand and not TSLP is the key regulator of IL-7–independent B-1 and B-2 B lymphopoiesis
|
Jensen, Christina T.
|
|
|
112 |
6 |
p. 2297-2304
|
artikel
|
| 19 |
Fully human monoclonal antibodies and targeted radionuclide therapy
|
Speer, Tod W.
|
|
|
112 |
6 |
p. 2584-2585
|
artikel
|
| 20 |
Histopathology of experimentally induced asthma in a murine model of sickle cell disease
|
Nandedkar, Sandhya D.
|
|
|
112 |
6 |
p. 2529-2538
|
artikel
|
| 21 |
How I treat cobalamin (vitamin B12) deficiency
|
Carmel, Ralph
|
|
|
112 |
6 |
p. 2214-2221
|
artikel
|
| 22 |
HTLV-1 infection: role of CTL efficiency
|
Bangham, Charles R.M.
|
|
|
112 |
6 |
p. 2176-2177
|
artikel
|
| 23 |
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
|
Koenen, Hans J.P.M.
|
|
|
112 |
6 |
p. 2340-2352
|
artikel
|
| 24 |
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)–specific CD8+ T cells in HTLV-1–associated neurologic disease
|
Sabouri, Amir H.
|
|
|
112 |
6 |
p. 2411-2420
|
artikel
|
| 25 |
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
|
Landgren, Ola
|
|
|
112 |
6 |
p. 2199-2204
|
artikel
|
| 26 |
Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells
|
Dai, Yun
|
|
|
112 |
6 |
p. 2439-2449
|
artikel
|
| 27 |
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
|
Nishimura, Ryosei
|
|
|
112 |
6 |
p. 2563-2574
|
artikel
|
| 28 |
Iron homeostasis: casting new roles
|
Finberg, Karin E.
|
|
|
112 |
6 |
p. 2181
|
artikel
|
| 29 |
Kindlin-3: a new gene involved in the pathogenesis of LAD-III
|
Mory, Adi
|
|
|
112 |
6 |
p. 2591
|
artikel
|
| 30 |
Leukemia takes center (late) stage
|
Davé, Utpal P.
|
|
|
112 |
6 |
p. 2175-2176
|
artikel
|
| 31 |
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD
|
Shah, Jatin J.
|
|
|
112 |
6 |
p. 2583
|
artikel
|
| 32 |
Many facets of bortezomib resistance/susceptibility
|
Kumar, Shaji
|
|
|
112 |
6 |
p. 2177-2178
|
artikel
|
| 33 |
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
|
Folgueras, Alicia R.
|
|
|
112 |
6 |
p. 2539-2545
|
artikel
|
| 34 |
MHC class I–specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response
|
Yawata, Makoto
|
|
|
112 |
6 |
p. 2369-2380
|
artikel
|
| 35 |
Microparticles facilitate neutrophil/platelet crosstalk
|
Andrews, Robert K.
|
|
|
112 |
6 |
p. 2174-2175
|
artikel
|
| 36 |
Mining the possibilities behind RBC alloimmunization
|
Cooling, Laura
|
|
|
112 |
6 |
p. 2180-2181
|
artikel
|
| 37 |
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
|
Oerlemans, Ruud
|
|
|
112 |
6 |
p. 2489-2499
|
artikel
|
| 38 |
MPDs: it's all in the family
|
Spivak, Jerry L.
|
|
|
112 |
6 |
p. 2173-2174
|
artikel
|
| 39 |
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production
|
Gross, Olaf
|
|
|
112 |
6 |
p. 2421-2428
|
artikel
|
| 40 |
Myeloproliferative disorders
|
Levine, Ross L.
|
|
|
112 |
6 |
p. 2190-2198
|
artikel
|
| 41 |
Nonmyeloablative conditioning for relapsed follicular lymphoma
|
van Besien, Koen
|
|
|
112 |
6 |
p. 2585-2586
|
artikel
|
| 42 |
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
|
Harir, Noria
|
|
|
112 |
6 |
p. 2463-2473
|
artikel
|
| 43 |
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies
|
Davies, Jeff K.
|
|
|
112 |
6 |
p. 2232-2241
|
artikel
|
| 44 |
Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1
|
Ahmad, Rasheed
|
|
|
112 |
6 |
p. 2360-2368
|
artikel
|
| 45 |
Resistance of mature T cells to oncogene transformation
|
Newrzela, Sebastian
|
|
|
112 |
6 |
p. 2278-2286
|
artikel
|
| 46 |
Response: Choice of conditioning for allogeneic transplantation in follicular lymphoma: nonmyeloablative or high-dose chemotherapy?
|
Khouri, Issa F.
|
|
|
112 |
6 |
p. 2586-2587
|
artikel
|
| 47 |
Response: More on disease anticipation in familial MPN
|
Landgren, Ola
|
|
|
112 |
6 |
p. 2588
|
artikel
|
| 48 |
Response: Multiple administrations of the fully human monoclonal antibody Ofatumumab
|
Hagenbeek, Anton
|
|
|
112 |
6 |
p. 2585
|
artikel
|
| 49 |
Response: Statistical power and validation of the MIPI
|
Hoster, Eva
|
|
|
112 |
6 |
p. 2583-2584
|
artikel
|
| 50 |
Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen
|
Safeukui, Innocent
|
|
|
112 |
6 |
p. 2520-2528
|
artikel
|
| 51 |
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I–associated neurologic disease
|
Enose-Akahata, Yoshimi
|
|
|
112 |
6 |
p. 2400-2410
|
artikel
|
| 52 |
Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors
|
Kared, Hassen
|
|
|
112 |
6 |
p. 2575-2578
|
artikel
|
| 53 |
Soluble CD22 as a tumor marker for hairy cell leukemia
|
Matsushita, Kakushi
|
|
|
112 |
6 |
p. 2272-2277
|
artikel
|
| 54 |
spib is required for primitive myeloid development in Xenopus
|
Costa, Ricardo M.B.
|
|
|
112 |
6 |
p. 2287-2296
|
artikel
|
| 55 |
Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders
|
Higgins, John M.
|
|
|
112 |
6 |
p. 2546-2553
|
artikel
|
| 56 |
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
|
Lunghi, Paolo
|
|
|
112 |
6 |
p. 2450-2462
|
artikel
|
| 57 |
TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice
|
Zhou, Yun
|
|
|
112 |
6 |
p. 2474-2483
|
artikel
|
| 58 |
Test-driving CARs
|
Cooper, Laurence J.N.
|
|
|
112 |
6 |
p. 2172-2173
|
artikel
|
| 59 |
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity
|
James, Chloe
|
|
|
112 |
6 |
p. 2429-2438
|
artikel
|
| 60 |
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele
|
Dorrance, Adrienne M.
|
|
|
112 |
6 |
p. 2508-2511
|
artikel
|
| 61 |
Toll-like receptors: lessons to learn from normal and malignant human B cells
|
Chiron, David
|
|
|
112 |
6 |
p. 2205-2213
|
artikel
|
| 62 |
TPO signaling: when the tyrosines go marching in(side)
|
Pozner, Roberto
|
|
|
112 |
6 |
p. 2171-2172
|
artikel
|
| 63 |
Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis
|
Shin, Jay W.
|
|
|
112 |
6 |
p. 2318-2326
|
artikel
|
| 64 |
Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
|
Wall, Meaghan
|
|
|
112 |
6 |
p. 2305-2317
|
artikel
|
| 65 |
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
|
Fourmentraux-Neves, Emmanuelle
|
|
|
112 |
6 |
p. 2381-2389
|
artikel
|
| 66 |
YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation
|
Hitchcock, Ian S.
|
|
|
112 |
6 |
p. 2222-2231
|
artikel
|
Tijdschrift beschrijving